An effective, affordable, and accessible HIV vaccine is 7-10 years away, according to scientists at the Medical Research Council of South Africa, in this week’s BMJ. However, its success depends on a complex interplay of politics, science, and public-private partnerships.
Equitable public-private partnerships between researchers, manufacturers, and distributors and partnerships between rich and poor countries are the best strategy for the development of the vaccine, say the authors. Successf
A team of Italian researchers has demonstrated in the laboratory for the first time that combining two of the newest anti-cancer targeted agents may produce a powerful new combination against breast cancer – and possibly many other cancers as well. Their findings are reported (Thursday 24 January) in the journal Annals of Oncology.*
They found that trastuzumab (Herceptin) and the as yet unlicensed drug ZD1839 (Iressa), act synergistically against two rogue genes commonly involved in breast c
Combining two separate observations of cells in brain tumours could enable doctors to improve the success rate of radiotherapy. Speaking today (23 January) at the Institute of Physics Simulation and Modelling Applied to Medicine conference in London, chemical engineer Dr Norman Kirkby from the University of Surrey will explain how using the correct time intervals between a sequence of low dose radiotherapy sessions could increase the chance of curing brain cancers that tend to resist treatment.
Researchers at the University of Bristol have discovered that not all babies who wheeze will develop asthma in later life.
Dr Andrea Sherriff and asthma experts from the Institute of Child Health in Bristol and St George`s Hospital Medical School in London studied around 10,000 children taking part in the Children of the 90s project in Bristol.
The researchers discovered that over 60% of babies who wheezed in the first six months had stopped by 3½ years of age. When they we
The herbal extract, butterbur, is as effective as antihistamines for treating hay fever, and does not have the sedative effects often associated with these drugs, finds a study in this week’s BMJ.
Researchers in Switzerland identified 125 patients with a history of hay fever. Patients received either butterbur extract tablets or a commonly used non-sedating antihistamine (cetirizine) as recommended by the manufacturers.
After two weeks, the effects of butterbur and cetirizine were s
Scientists believe that they have found a chemical responsible for increasing cardiovascular risk, it was revealed. And crucially they have identified how it is made and destroyed in the body raising the possibilty that new drugs to reduce the risk of heart disease are around the corner. A team of scientists based at the new British Heart Foundation (BHF) Laboratories at UCL first identified ADMA as a naturally occurring substance that blocks the production of a gas made by the body – Nitric Oxide. N